While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

If you or a loved one has sleep apnea, you may ... treatments include breathing devices, such as continuous positive airway pressure (CPAP) machines and lifestyle changes to promote weight loss.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive ... Zepbound is also prescribed to treat moderate to severe obstructive sleep apnea in adults with ...

According to The New York Times, the most popular of the drugs ... approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss.

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...